Key facts
- It has raised $3.2M.
- Notable investors include Alpen Capital (Investor), RiverPark Ventures, BAM Ventures, BrandProject, Listen Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Good Bacteria
- ·The full record, as it builds
Funding rounds
No funding rounds for Good Bacteria are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Good Bacteria
Developer of synbiotic drugs designed to improve gut health. The company offers rotational synbiotic formulations that combine probiotics, prebiotics, and postbiotics in weekly cycles, enabling consumers to achieve optimal digestion, stronger immunity, and balanced microbiome health.
- Sector
- Healthcare
- HQ
- Portland, OR, United States
- Founded
- 2023
- Employees
- 6
- Website
- itsgoodbacteria.com/
- Ownership
- Privately Held (backing)
Good Bacteria doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Good Bacteria shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Good Bacteria in its N-PORT filings yet. We sweep new filings monthly.